J&J Ads Contain Misleading Safety Stats On Tremfya, Novartis Lawsuit Claims
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.…
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.…
A new ISMP report warns that the psoriasis drug Stelara appears to be linked to a high rate of cancer.…
Humira and Enbrel were the drugs most linked to injury reports last year, including injection site reactions, infections and cases of cancer, according to a new report.…
A new study reveals that some dermatologists are prescribing steroids to psoriasis patients in defiance of medical guidelines on treating the skin condition.…
The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back to June. …
Side effects of Enbrel, Humira and other similar medications in the same class, which are used to treat inflammatory ailments, may increase the risk of a Listeria infection or Legionnaire’s disease, according to federal health regulators. …
Federal drug regulators are receiving an increasing amount of blood cancer reports from users of some drugs designed to treat inflammatory bowel disease (IBD). …
The label information on the multiple sclerosis drug Tysabri is being updated to reflect new data on the risk of a serious, and sometimes deadly, brain infection that has killed at least 21 patients using the drug. …
A Raptiva infection lawsuit has been filed by a Massachusetts man who claims that the recalled psoriasis drug caused him to develop meningitis and acute retinal necrosis, which left him legally blind. …
A Texas man who was diagnosed with classic Hodgkin’s lymphoma has filed a Raptiva lawsuit, alleging that the recalled psoriasis drug caused him to develop the cancer.…